Centrosome aberrations in chronic myeloid leukemia (CML) are correlated with disease progression and chromosome instability.

被引：0
|
作者：
Giehl, M
Fabarius, A
Zheng, C
Frank, O
Hochhaus, A
Hafner, M
Hehlmann, R
Seifarth, W
机构：
[1] Univ Heidelberg, Med Univ Klin Mannheim 3, D-6800 Mannheim, Germany
[2] Fachhsch Mannheim, Inst Biotechnol, Mannheim, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2949
引用
收藏
页码：806A / 806A
页数：1
相关论文
共 50 条
  • [21] Prognostic Factors in Chronic Myeloid Leukemia (CML)
    Hochhaus, Andreas
    ONKOLOGIE, 2008, 31 (11): : 576 - 578
  • [22] Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate
    C Schoch
    T Haferlach
    W Kern
    S Schnittger
    U Berger
    R Hehlmann
    W Hiddemann
    A Hochhaus
    Leukemia, 2003, 17 : 461 - 463
  • [23] Molecular monitoring in chronic myeloid leukemia (CML)
    Izzo, Barbara
    Accetta, Raffaella
    Caruso, Simona
    De Angelis, Biagio
    Del Prete, Ciro
    Errichiello, Santa
    Galdiero, Alessandra
    Casadei, Giada Muccioli
    Musella, Filomena
    Quintarelli, Concetta
    Visconti, Roberta
    Pane, Fabrizio
    BIOCHIMICA CLINICA, 2015, 39 (02) : 94 - 99
  • [24] Advances in Immunotherapy of Chronic Myeloid Leukemia CML
    Held, Stefanie Andrea Erika
    Heine, Annkristin
    Mayer, Karin Tina
    Kapelle, Mario
    Wolf, Dominik Georg Friedrich
    Brossart, Peter
    CURRENT CANCER DRUG TARGETS, 2013, 13 (07) : 768 - 774
  • [25] FRONTLINE THERAPY OF CHRONIC MYELOID LEUKEMIA (CML)
    Kantarjian, Hagop
    LEUKEMIA RESEARCH, 2014, 38 : S1 - S1
  • [26] Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate
    Schoch, C
    Haferlach, T
    Kern, W
    Schnittger, S
    Berger, U
    Hehlmann, R
    Hiddemann, W
    Hochhaus, A
    LEUKEMIA, 2003, 17 (02) : 461 - 463
  • [27] Role of Shelterin Complex and Alternative Telomere Lengthening in Genomic Instability and Disease Progression in Chronic Myeloid Leukemia
    Stoklosa, Tomasz
    Deregowska, Anna
    Pruszczyk, Katarzyna
    Solarska, Iwona
    Machnicki, Marcin M.
    Adamczyk, Jagoda
    Seferynska, Ilona
    Lewinska, Anna
    Wnuk, Maciej
    BLOOD, 2016, 128 (22)
  • [28] Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia
    Chandran, Ramachandran Krishna
    Geetha, Narayanan
    Sakthivel, Kunnathur Murugesan
    Kumar, Raveendran Suresh
    Krishna, Kumarapillai Mohanan Nair Jagathnath
    Sreedharan, Hariharan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [29] Telomere length in patients with acute myeloid leukemia correlates with karyotypic instability.
    Hartmann, U
    Brummendorf, TH
    Balabanov, S
    Illmer, T
    Soucek, S
    Kanz, L
    Ehninger, G
    Schaich, M
    BLOOD, 2003, 102 (11) : 867A - 868A
  • [30] Identification of Progression-Associated Mutations in Chronic Myeloid Leukemia (CML) By Comparative Genomic Analysis
    Awad, Shady Adnan
    Kankainen, Matti
    Eldfors, Samuli
    Yadav, Bhagwan
    Kytola, Soili
    Ellonen, Pekka
    Kamel, Mahmoud
    Heckman, Caroline A.
    Porkka, Kimmo
    Mustjoki, Satu
    BLOOD, 2017, 130
12345